In Partnership with Total Orphan Drugs
Total Orphan Drugs are partnering with the World Orphan Drug Congress USA to bring you the news and developments from this year’s event. Together we will bring you the latest in news, analysis, and developments in the run-up to, and on site at WODC USA 2015.
Click to browse the latest in insights and analysis of the orphan drug industry, along with the latest interviews and infographics.
Get the latest orphan drug news from the USA direct from the World Orphan Drug Congress Team USA in New York.
Join Total Orphan Drugs and rare disease steakholders from around the world on twitter in the run-up to, and on site at the World Orphan Drug Congress USA.
Share this page
The World Orphan Drug Congress USA
The World Orphan Drug Congress is the best opportunity you will find for networking with leading biotechs, pharma, advocacy groups, payers, and government bodies all in one place.
DOWNLOAD THE BROCHURE NOW
Call for Guest Writers
This opportunity is open to all would-be commentators from all corners of the rare disease industry – from students, bloggers and journalists, to researchers and academics.
Join us at the World Orphan Drug Congress USA 2015 for 2 days in Washington D.C. and work with our writers to cover WODC USA and place your work infront of our thousands of readers.
- FREE conference entry
- FREE entry to pre-conference workshops
- Network at the worlds biggest Orphan Drug event
- A chance to put your thoughts and analysis in front of a large online audience
- Get the industry talking about your articles
Our agenda covers discussions ranging from pricing to patient engagement to global market access and commercialization. Learn both sides of the sustainability argument and hear firsthand how payers look at reimbursement.
Greater payer stakeholder involvement
Payers are the ones who ultimately get those orphan drugs to the patients – and this year, we have an unprecedented and unrivalled number of payers at our event.
Unmatched global representation
Learn from experts in over 8 different countries how to commercialize and gain market access in their regions as part of our “International Markets” roundtable feature.
The Latest News from the US
The United states represents the pinnacle of Orphan Drug development and access. Here we have the latest news and features from our team in New York, aimed specifically at the US orphan drug market.
Understanding the Unique Challenges and Opportunities in Rare Disease Drug DevelopmentFebruary 13, 2017
Tackling the Rare Diseases therapy deficit –the nonsense mutation read-through agentFebruary 6, 2017
Adaptive Biomedical Innovation: Innovating How We InnovateJanuary 30, 2017
Maintaining a relationship based on trust: finding common goals with a KOL and its institutionJanuary 23, 2017
Delivering Hope – A First-In-Class Orphan Drug Comes to MarketJanuary 19, 2017
‘Significant Benefit’ in the European Regulatory Framework for Orphan Medicinal ProductsJanuary 16, 2017
Creating Medicines with Real Value for Orphan DiseasesDecember 19, 2016
Re-engineering the process rather than new legislations: Europe’s approach to get more, better, faster, cheaper orphan drugsDecember 12, 2016
Downloadable Content from the WODC USA Team
Bringing you the latest analysis and insights in the Americas’ orphan drug industry.
Join the Discussion
Total Orphan Drugs will be hosting all of the World Orphan Drug Congress USA’s online activity. With tweet chats, downloads and interviews in the run-up to the conference, and live news and discussion on-site during the conference. Join the discussion on twitter and on Total Orphan Drugs.
Get in TouchGet in touch with the World Orphan Drug Congress USA team to see how our event can work for you.
Share this page